Saab 9-3 some revisions in 2011 for the 2012 model year. Changes were in the engine range with an overall reduction in diesel and petrol engine fuel consumption of 12% and 7% respectively. An entry-level 163 hp, 2.0-litre gasoline / BioPower engine was added for 9-3 saloon, estate, and 9-3X models with Saab XWD. Other changes included rear badging in line with all new Saab 9-5 saloon, 'ice block' style headlights, New bumper design, titanium metallic effect trim around instrument panel, gearshift, doors and glove box. Aero gets graphite fiber effect. Contrast stitching on leather upholstery. In most markets, car was badged
7+3 (chemotherapy) anthracyclines. Addition of glucocorticoids (like prednisolone) or methotrexate or alkylating drugs (like cyclophosphamide or melphalan) to the "7+3" regimen is also of no benefit in AML. The addition of etoposide to the standard "7+3" regimen is "sometimes" of benefit in poor-risk patients (many of which are primary refractory to standard "7+3" induction regimens). It gave rise to the so-called ADE (or DAE = DA + etoposide) induction regimen in AML. The ADE induction (unlike, say, combinations of 7+3 with vinca alkaloids or prednisolone) is still sometimes used, especially in poor-risk AML patients. The addition of 6-thioguanine gave rise to the